Fenfluramine Hydrochloride Synthesis Purity Control

The patent applies preliminary action by using highly pure 3-(trifluoromethyl) aniline hydrochloride as a starting material with purity greater than 99.5% by HPLC, and by purifying intermediate compounds (1-(3-(trifluoromethylphenyl) propan-2-one and 1-chloro-2-(3-(trifluoromethyl) phenyl) diazene) through specific purification steps before using them in subsequent reactions. This preliminary purification of reactants and intermediates prevents impurity formation in the final product, achieving Fenfluramine hydrochloride with purity greater than 99.5% by HPLC and free from specified impurities.

The patent applies the extraction principle by removing harmful impurities from the reaction mixture through specific purification steps. Impurities such as acetate impurity, dimer impurity, Fenfluramine Regio isomers, Fenfluramine Alcohol, and norfenfluramine are extracted and separated from the main product through purification processes including filtration, washing, and recrystallization, resulting in a pure final product.

The patent makes the process industrially feasible and economical by using highly pure starting materials and intermediates from the beginning, which prevents the formation of multiple impurity types (acetate impurity, dimer impurity, Regio isomers, Alcohol, and norfenfluramine). This approach eliminates the need for complex purification steps later in the process, reducing overall process complexity and cost while achieving >99.5% HPLC purity.

The patent converts the potential harm of impurity formation into a benefit by designing the synthesis route to inherently prevent impurity generation. By using highly pure 3-(trifluoromethyl) aniline hydrochloride as starting material and controlling reaction conditions, the process transforms what would be a problematic impurity generation issue into a clean synthesis approach that produces >99.5% pure product without requiring extensive purification.